3 reasons to buy Fletcher Building Limited (Australia)

After releasing upbeat results, here are 3 reasons why Fletcher Building Limited (Australia) (ASX:FBU) could be worth buying

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Recent results released by Fletcher Building Limited (Australia) (ASX: FBU) were strong and showed that the company delivered an 11% year-on-year increase in earnings. With shares having performed reasonably well during the course of 2014 (they are up 7% since the turn of the year) and the Aussie and New Zealand housing markets showing strength, now could be a good time to add Fletcher Building to your portfolio. Here are three key reasons why.

  1. While an 11% increase in the bottom line was impressive, Fletcher Building is all set to deliver even better results moving forward. Indeed, the company is due to post earnings numbers that are 22.9% higher in each of the next two years. This means that in two years' time, the company's bottom line could be around 51% larger than at present, which would clearly be great news for investors. Obviously, the RBA's decision to hold interest rates at 2.5% is giving the housing market (and Fletcher Building) a big boost.
  2. Fletcher Building also offers great value for money right now. For instance, shares in the company currently trade on a price to earnings growth (PEG) ratio of just 0.8. This is massively below the ASX's PEG of 2 and shows that, while Fletcher Building has a P/E that many investors may be put off by (it currently stands at 18.4 versus 16.4 for the ASX), the company actually offers exceptional growth prospects at a very reasonable price.
  3. Due to its strong earnings growth potential, Fletcher Building is also due to increase its dividend at a rapid rate. For example, over the next two years it is expected to increase dividends per share by 10% per annum. This should help to raise the company's yield (assuming the share price stays where it is), although the current yield is hardly lacking. While unfranked, Fletcher Building currently yields 4.2%, which means that it offers strong income potential, stunning growth prospects and a valuation that seems rather low given its upbeat recent results. As such, it could prove to be a sound investment at current price levels.
Motley Fool contributor Peter Stephens does not own shares in any of the companies mentioned

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »